Press Releases

Seasoned Data Science Leader Named President and CEO of M2GEN

M2GEN, a company focused on transforming cancer care through data and informatics, has announced the appointment of Jim Gabriele as president and chief executive officer. Gabriele is a seasoned entrepreneur and data science leader who most recently served as senior vice president and chief strategy & data science officer, medical devices sector, at Johnson & Johnson. Gabriele was selected to lead M2GEN based on his track record of leading growth initiatives and digital transformations, deep understanding of biopharma, and capability-building skills in key technology and data...

Komodo Health Acquires Breakaway Partners to Improve Patient Access to Effective Therapies

Komodo Health has acquired Breakaway Partners, a market access software company for the life sciences industry. This acquisition brings together Komodo’s Healthcare Map and software with Breakaway Partners’ formulary data, policy criteria, and analytics platform to create the industry’s first enterprise market access solution suite based on a comprehensive, real-time view of real-world outcomes and costs. As healthcare payers and providers continue the shift to value-based payment models, which incentivize the use of the most effective therapies, the market access analytics field has become critical to...

Komodo Health Names Bill Madigan as Chief Revenue Officer

Komodo Health has announced that Bill Madigan has been appointed as the company’s chief revenue officer. With more than 25 years of experience commercializing software and services in healthcare and life sciences, Madigan will oversee Komodo’s customer-facing team and shape its commercial strategy. Madigan brings a track record of expertise, entrepreneurship, and innovation in healthcare technology. Prior to his position at Komodo Health, he held several leadership roles across Optum’s work with the top 20 pharmaceutical companies and drove revenue growth in the provider analytics business....

Hims & Hers Expands Mental Health Offerings to Include Individual Online Therapy

McKesson Ventures portfolio company Hims & Hers recently announced that it has expanded its mental health offerings to include individual online therapy. Built to complement the platform’s existing services including access to online psychiatry and free, educational support group sessions, the new individualized therapy offering will provide more convenience, comfort, and cost savings to mental health services. Individual online therapy is available at $99 per session. While online psychiatry provides patients with access to healthcare providers who can prescribe medications for conditions such as anxiety and...

Empowerment Model: A New Partnership Model for Maximum Efficiency, Cost Savings, and Control, Upcoming Webinar Hosted by Xtalks

Two experts from Clinical Ink will present a webinar on the benefits of subscription models for clinical trials on July 13, 2021, at 11 a.m. ET. In the webinar, hosted by Xtalks, Clinical Ink Senior Director, Outcome Solutions Kim Romanello; and Manager, Product Innovation Brady Keeter will discuss how subscription-based models for clinical trials can allow greater flexibility, reduced costs, and customized solutions and services. With increased attention on decentralized clinical trials, a growing number of sponsors and contract research organizations (CROs) plan to adopt direct data...

HumanFirst joins the FDA, HHS and more than 20 organizations and leading health companies to launch the Digital Health Measurement Collaborative Community (DATAcc)

More than 20 organizations and companies, including McKesson Ventures portfolio companies Aetion, Evidation Health, and Xealth, have joined together with other members of the Digital Medicine Society (DiMe) to create the Digital Health Measurement Collaborative Community (DATAcc), an effort to develop best practices and streamline approaches to measuring health using digital technologies. DATAcc comprises leaders from across the government, nonprofit, and private sectors, including healthcare systems, medical technology companies, patient advocates, biopharma, and policy organizations. The collaborative will use interdisciplinary expertise, data, and use cases to...

PicnicHealth Partners with Komodo Health to Enrich Its Research Platform Utilizing Real-World Patient Data

Komodo Health and PicnicHealth have announced a partnership to support real-world evidence research programs for complex chronic illnesses like multiple sclerosis and hemophilia. With this partnership, PicnicHealth will enrich its database of de-identified patient medical records with data from Komodo’s Healthcare Map. The combined breadth and depth of real-world patient data will help support research efforts to close gaps in care, address unmet patient needs, and streamline clinical development efforts to deliver life-saving therapies to patients. By integrating PicnicHealth’s data with Komodo Health’s Healthcare Map, PicnicHealth’s...

Geisinger Health Plan Makes Searching for a Provider Easier With Kyruus-HealthSparq Integration

Geisinger Health Plan has expanded its partnership with HealthSparq, a healthcare guidance and transparency technology company serving health plans, and its parent company, Kyruus. GHP is the first health plan to use HealthSparq’s new Path to Care solution to power its provider directory with richer, more accurate data that helps members better navigate their healthcare choices. Path to Care enables health plans to leverage enriched provider data from participating health systems on the Kyruus platform to enhance their online provider search experiences. According to the Centers for...

Leading Real-World Data and Analytics Organizations Form Industry Coalition to Advance Policies to Support Regulatory Use of Real-World Evidence

McKesson Ventures portfolio company Aetion is one of the five real-world data (RWD) and analytics organizations that have banded together to form the RWE Alliance, an industry coalition dedicated to advancing the use of real-world evidence (RWE) to support regulatory decisions. The other members of the Alliance are Flatiron Health, IQVIA, Syapse, and Tempus. The RWE Alliance intends to engage with the FDA and Congress to advocate for policies that advance the use or RWE in regulatory decision-making and benefit patients. The RWE Alliance will collaborate...

Aetion Closes $110M Series C Funding Round Led by Warburg Pincus

On May 11, Aetion announced a $110 million Series C fundraise. The fundraise was led by growth equity firm Warburg Pincus, with additional funding from new investors B Capital and Foresite Capital and existing investors New Enterprise Associates (NEA) and Flare Capital Partners. This additional $110 million brings Aetion’s total raised funding to $212 million. Aetion, a leader in the real-world evidence (RWE) space, nearly doubled its revenue and had a 100% customer renewal rate in 2020. “In a post-COVID era, we have an imperative to use...